<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta http-equiv="Content-Style-Type" content="text/css" /><meta name="generator" content="Aspose.Words for .NET 13.4.0.0" /><title>This submission is made on behalf of the International Scientific Forum on Home Hygiene (IFH)(www</title></head><body><div><p style="margin:0pt"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:center"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">Written evidence submitted by the International Scientific Forum on Home Hygiene (IFH) (AMR0031)</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">This submission is made on behalf of the International Scientific Forum on Home Hygiene (IF</span><span style="font-family:'Times New Roman'; font-size:11pt">H</span><span style="font-family:'Times New Roman'; font-size:11pt">).</span><a name="_ftnref1"></a><a href="#_ftn1">[1]</a><span style="font-family:'Times New Roman'; font-size:11pt">  The IFH is a not for-profit non government agency which is working to develop and promote a science-based approach to hygiene/infection prevention in home and everyday life settings.  Registered Charity No:CH-660 2131998-6</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">This submission addresses the following question:</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">What are the strengths and weaknesses of the Government’s 2013-2018 strategy for tackling antimicrobial resistance? What changes might be made to further strengthen the Government’s action plan?</span></p><ol type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 31.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Although this plan prioritizes the need to develop and promote strategies to prevent the spread of antibiotic resistant strains, there is little or no mention of the need to address the circulation of strains in the community as well as in health care settings. We ask that you take account of the following|:</span></li><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 31.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">In tackling antibiotic resistance, and there is increasing awareness that hygiene measures are a central part of reducing the spread of drug-resistant organisms.</span><a name="_ftnref2"></a><a href="#_ftn2">[2]</a><span style="font-family:'Times New Roman'; font-size:11pt">  </span></li><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 31.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Currently, the focus is on preventing </span><span style="font-family:'Times New Roman'; font-size:11pt">nosocomial</span><span style="font-family:'Times New Roman'; font-size:11pt"> infections arising from spread of resistant superbugs in hospitals, but it is increasingly recognised that this is just as much a home and community problem.   In the community, otherwise healthy people can become persistent skin carriers of MRSA,</span><span style="font-family:'Times New Roman'; font-size:7.33pt; vertical-align:super"> </span><span style="font-family:'Times New Roman'; font-size:11pt">or faecal carriers of </span><span style="font-family:'Times New Roman'; font-size:11pt">enterobacteria</span><span style="font-family:'Times New Roman'; font-size:11pt"> strains which carry multi-antibiotic resistance factors (</span><span style="font-family:'Times New Roman'; font-size:11pt">e.g</span><span style="font-family:'Times New Roman'; font-size:11pt"> NDM-1 or ESBL-producing strains). Because these people are healthy i.e. there is no evidence of clinical disease, the risks are not apparent until they are, for example, admitted to hospital, when they can become “self infected” with their own resistant organisms following a surgical procedure, and then spread it to other patients.  It is thought that t</span><span style="font-family:'Times New Roman'; font-size:11pt">he major source of </span><span style="font-family:'Times New Roman'; font-size:11pt">nosocomial</span><span style="font-family:'Times New Roman'; font-size:11pt"> pathogens is the patient’s endogenous flora.</span><a name="_ftnref3"></a><a href="#_ftn3">[3]</a><span style="font-family:'Times New Roman'; font-size:11pt">   Data on the prevalence on antibiotic resistance strains in the community is addressed in an IFH review.</span><a name="_ftnref4"></a><a href="#_ftn4">[4]</a></li><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 31.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Sometimes these infections occur in the community, as happened in 2005 when a young soldier acquired what should have been an easily treatable skin infection from a PVL-producing strain of MRSA, but subsequently died.</span><a name="_ftnref5"></a><a href="#_ftn5">[5]</a><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">As persistent nasal, skin or bowel carriage </span><span style="font-family:'Times New Roman'; font-size:11pt">in the healthy population spreads “silently” with and between communities and across the world, risks from drug resistant strains in both hospitals and the community increases. </span></li><li style="font-family:'Times New Roman'; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 31.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">This means that hygiene measures in home and everyday life settings are just as important as in healthcare settings in the fight against antibiotic resistance, not just because they reduce the need for antibiotic prescribing (i.e. reduce the number of infections requiring antibiotic treatment) they can also reduce the spread of resistant strains in the healthy community, reducing not only the spread infections with drug resistant strains, but also the rate of carriage in the healthy population</span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">November 2013</span></p><p style="margin:0pt"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p></div><hr style="width:33%; height:1px; text-align:left" /><p style="margin:0pt"><a name="_ftn1"></a><a href="#_ftnref1">[1]</a><span style="font-family:Calibri; font-size:10pt"> </span><span style="font-family:'Times New Roman'; font-size:10pt">www.ifh-homehygiene.org</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 14.2pt; text-indent:-14.2pt"><a name="_ftn2"></a><a href="#_ftnref2">[2]</a><span style="font-family:Arial; font-size:11pt"> </span><span style="font-family:Arial; font-size:11pt">              </span><span style="font-family:'Times New Roman'; font-size:10pt">Recommendations for future collaboration between the U.S. and EU. Transatlantic Taskforce on Antimicrobial Resistance 2011.  Available at:</span><span style="font-family:'Times New Roman'; font-size:10pt"> </span><span style="font-family:'Times New Roman'; font-size:10pt"> </span><a href="http://ecdc.europa.eu/en/activities/diseaseprogrammes/TATFAR/Documents/210911_TATFAR_Report.pdf"><span style="font-family:'Times New Roman'; font-size:10pt">http://ecdc.europa.eu/en/activities/diseaseprogrammes/TATFAR/Documents/210911_TATFAR_Report.pd</span></a><span style="font-family:'Times New Roman'; font-size:10pt">f.</span></p><p style="font-size:10pt; line-height:115%; margin:0pt 0pt 10pt 14.2pt; text-indent:-14.2pt"><a name="_ftn3"></a><a href="#_ftnref3">[3]</a><span style="font-family:'Times New Roman'; font-size:10pt"> </span><span style="font-family:'Times New Roman'; font-size:10pt">              </span><span style="font-family:'Times New Roman'; font-size:10pt">Weber DJ, </span><span style="font-family:'Times New Roman'; font-size:10pt">Rutala</span><span style="font-family:'Times New Roman'; font-size:10pt"> WA, Miller M, </span><span style="font-family:'Times New Roman'; font-size:10pt">Huslage</span><span style="font-family:'Times New Roman'; font-size:10pt"> K, </span><span style="font-family:'Times New Roman'; font-size:10pt">Sickbert-Bennet</span><span style="font-family:'Times New Roman'; font-size:10pt"> E. Role of hospital surfaces in the transmission of emerging health care associated pathogens: </span><span style="font-family:'Times New Roman'; font-size:10pt">Norovirus</span><span style="font-family:'Times New Roman'; font-size:10pt">,  Clostridium </span><span style="font-family:'Times New Roman'; font-size:10pt">difficile</span><span style="font-family:'Times New Roman'; font-size:10pt">, and </span><span style="font-family:'Times New Roman'; font-size:10pt">Acinetobacter</span><span style="font-family:'Times New Roman'; font-size:10pt"> species. Am J Infect Control 2010;38:s27-33.</span></p><p style="margin:0pt; text-align:justify"><a name="_ftn4"></a><a href="#_ftnref4">[4]</a><span style="font-family:'Times New Roman'; font-size:10pt"> S.F Bloomfield. Spread of antibiotic resistant strains in the home and community. International Scientific Forum on Home Hygiene.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:10pt">http://www.ifh-homehygiene.org/review/spread-antibiotic-resistant-strains-home-and-community</span></p><h1 style="margin:0pt 0pt 0pt 14.2pt; page-break-after:avoid; text-align:justify; text-indent:-14.2pt"><a name="_ftn5"></a><a href="#_ftnref5">[5]</a><span style="font-family:'Times New Roman'; font-size:10pt; font-weight:normal"> </span><span style="font-family:'Times New Roman'; font-size:10pt; font-weight:normal">              </span><span style="font-family:'Times New Roman'; font-size:10pt; font-style:italic; font-weight:normal">Morgan M. Staphylococcus </span><span style="font-family:'Times New Roman'; font-size:10pt; font-style:italic; font-weight:normal">aureus</span><span style="font-family:'Times New Roman'; font-size:10pt; font-weight:normal">, Panton-Valentine </span><span style="font-family:'Times New Roman'; font-size:10pt; font-weight:normal">leukocidin</span><span style="font-family:'Times New Roman'; font-size:10pt; font-weight:normal">, and necrotising pneumonia. British Medical Journal 2005; 331: 793–794</span></h1></body></html>